×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • BAKER BROS. ADVISORS LP (Data extracted from 13F, 13D, 13G and Form 4)

BAKER BROS. ADVISORS LP

AUM: $21.98 B
13-F Portfolio Value: $10.31 B
Last 13-F Filed: Q2 2025
Concentration in top 10: 81.62%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
INCYIncyte Corporation19.58%30,743,275$2,093,617,0283,3220.01%$68.113F
ACADACADIA Pharmaceuticals Inc.8.65%42,896,690$925,281,60318,7740.04%$21.5713F
INSMInsmed Incorporated7.26%7,712,900$776,226,2562,332,27443.35%$100.6413F
SMMTSummit Therapeutics Inc.6.71%33,722,974$717,624,8879,298,10938.07%$21.2813F
RVMDRevolution Medicines, Inc.3.22%9,364,972$344,537,3201,428,00017.99%$36.7913F
CELCCelcuity Inc.2.93%7,745,692$309,130,5682,295,24742.11%13D
KYMRKymera Therapeutics, Inc.2.71%6,651,429$290,268,362655,50010.93%$43.6413F
ALKSAlkermes plc1.72%6,410,603$183,407,3521,927,31842.99%$28.6113F
RAREUltragenyx Pharmaceutical Inc.0.94%2,772,692$100,815,0811,196,57875.92%$36.3613F
EWTXEdgewise Therapeutics, Inc.0.90%7,305,940$95,780,8731,150,00018.68%$13.1113F
KNSAKiniksa Pharmaceuticals International, plc0.73%2,824,669$78,158,5916,3460.23%$27.6713F
IMTXImmatics N.V.0.51%10,168,901$54,708,6872,893,07139.76%$5.3813F
GPCRStructure Therapeutics Inc.0.49%2,508,767$52,031,8282,147,202593.86%$20.7413F
IDYAIDEAYA Biosciences, Inc.0.42%2,118,728$44,535,6631,056,60599.48%$21.0213F
BNTXBioNTech SE0.37%368,923$39,279,232323,892719.26%$106.4713F
MRUSMerus N.V.0.28%574,377$30,212,230350,877156.99%$52.613F
PRAXPraxis Precision Medicines, Inc.0.27%689,488$28,992,970357,955107.97%$42.0513F
NTLAIntellia Therapeutics, Inc.0.23%2,675,674$25,097,8222,031,558315.4%$9.3813F
IRONDisc Medicine, Inc.0.17%337,050$17,850,168260,000337.44%$52.9613F
CLDXCelldex Therapeutics, Inc.0.13%665,370$13,540,280417,726168.68%$20.3513F
XENEXenon Pharmaceuticals Inc.0.11%370,208$11,587,51022,8006.56%$31.313F